RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

RYAAY

63.53

-0.35%↓

KNEBV.FI

53.58

-0.11%↓

MTX1

376.6

-0.63%↓

WRT1V.FI

24.37

+1.58%↑

BVI

26.84

+0.9%↑

Search

Enagas SA

Cerrado

SectorAcciones industriales

13.21 -0.53

Resumen

Variación precio

24h

Actual

Mínimo

13.16

Máximo

13.315

Métricas clave

By Trading Economics

Ingresos

-53M

111M

Ventas

46M

250M

P/B

Media del Sector

25.308

42.612

BPA

0.25

Rentabilidad por dividendo

4.53

Margen de beneficio

44.411

Empleados

1,388

EBITDA

14M

121M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+10.98% upside

Dividendos

By Dow Jones

Rentabilidad por dividendo

Media del Sector

4.53%

2.27%

Próximas Ganancias

21 oct 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-42M

3.5B

Apertura anterior

13.74

Cierre anterior

13.21

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

209 / 461 Clasificación en Industrials

Puntuación técnica

By Trading Central

Confianza

Bearish Evidence

Enagas SA Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

4 ago 2025, 21:42 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Cabot to Acquire Mexico Carbon Manufacturing From Bridgestone

4 ago 2025, 21:21 UTC

Ganancias
Principales Movimientos del Mercado

Vertex Stock Falls After Pain-Drug Setback, Despite Stronger 2Q Earnings -- Update

4 ago 2025, 20:45 UTC

Ganancias

Vertex Pharmaceuticals Swings to 2Q Profit as Sales Climb

4 ago 2025, 19:15 UTC

Principales Movimientos del Mercado

TransMedics Group Shares Rise on FDA Approval for Clinical Trial

4 ago 2025, 23:41 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

4 ago 2025, 23:41 UTC

Charlas de Mercado

Nikkei May Rise on Fed Stimulus Hopes

4 ago 2025, 23:28 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

4 ago 2025, 23:28 UTC

Charlas de Mercado

Gold Seen Stuck in Range as Investors Await Fed's Next Move -- Market Talk

4 ago 2025, 21:30 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 21:21 UTC

Ganancias
Adquisiciones, fusiones, absorciones

Berkshire Stock Was Hammered Monday. It's Like 1999 Again. -- Barrons.com

4 ago 2025, 21:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Expectations. -- Barrons.com

4 ago 2025, 20:25 UTC

Charlas de Mercado

India Hits Back Over Russian Oil Purchases -- Market Talk

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss $938M >RIG

4 ago 2025, 20:25 UTC

Ganancias

Transocean 2Q Loss/Shr $1.06 >RIG

4 ago 2025, 20:18 UTC

Ganancias

Palantir Stock Jumps. Earnings Blew Past Wall Street's Stratospheric Expectations. -- Barrons.com

4 ago 2025, 20:15 UTC

Ganancias

Vertex Pharma: Guidance Includes Immaterial Cost Impact From Tariffs in 2025 Based on Currently Known Tariff Rates and Regulations >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharmaceuticals Reiterated FY25 Fincl Guidance >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: Mark Bunnage, D.Phil., SVP of Global Research, to Assume Role of CSO Effective Feb 1, 2026 >VRTX

4 ago 2025, 20:14 UTC

Ganancias

Vertex Pharma: David Altshuler, Chief Scientific Officer, Intends to Retire Aug 1, 2026 >VRTX

4 ago 2025, 20:13 UTC

Ganancias

Vertex Pharmaceuticals Backs FY25 Rev $11.85B-$12B >VRTX

4 ago 2025, 20:09 UTC

Ganancias

Viper Energy: Initiating Avg Daily Production Guidance for 3Q of 46,000 to 49,000 Bo/d (86,000 to 92,000 Boe/d) >VNOM

4 ago 2025, 20:06 UTC

Ganancias

Palantir Earnings Blow Past Wall Street's Stratospheric Expectations -- Barrons.com

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Net $1.03B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Adj EPS $4.52 >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q Rev $2.96B >VRTX

4 ago 2025, 20:01 UTC

Ganancias

Vertex Pharmaceuticals 2Q EPS $3.99 >VRTX

4 ago 2025, 19:41 UTC

Charlas de Mercado

U.S. Natural Gas Futures Settle Lower -- Market Talk

4 ago 2025, 19:28 UTC

Charlas de Mercado

U.S. Hiring Expected to Recover Once Uncertainty Dissipates -- Market Talk

4 ago 2025, 19:07 UTC

Charlas de Mercado

Oil Extends Losing Streak As OPEC+ to Raise Output -- Market Talk

4 ago 2025, 18:27 UTC

Charlas de Mercado

Gold Climbs on Rate Cut Speculation -- Market Talk

Comparación entre iguales

Cambio de precio

Enagas SA Esperado

Precio Objetivo

By TipRanks

10.98% repunte

Estimación a 12 meses

Media 14.65 EUR  10.98%

Máximo 17.7 EUR

Mínimo 12.8 EUR

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Enagas SA Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

3 ratings

1

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

13.31 / 13.69Soporte y Resistencia

Corto Plazo

Bearish Evidence

Medio plazo

Strong Bullish Evidence

Largo Plazo

Bullish Evidence

Sentimiento

By Acuity

209 / 461 Clasificación en Acciones industriales

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Enagas SA

Enagás, S.A. develops, operates, and maintains gas infrastructures in Spain and internationally. It operates through Gas Transmission, Regasification, and Storage of Gas segments. The company provides gas transmission services through primary and secondary transmission pipelines; and natural gas regasification services, as well as operates underground storage facilities. It is also involved in the operation and technical management of the basic network and secondary transportation network for natural gas. In addition, the company engages in the financial management activities; development of industrial projects and activities relating to LNG terminals, and hydrogen production and transport infrastructures; development and implementation of facilities for the supply of natural gas as fuel for vehicles, including its design, construction, and maintenance; and provision of commercial services for the purpose of enhancing the daily operational management of gas shippers. Further, it is involved in the development of projects to promote the role of renewable gases in the energy transition; and production of solar energy. Enagás, S.A. was incorporated in 1972 and is headquartered in Madrid, Spain.